Universitat de Barcelona

<table class="infobox infobox-institution">
<tr>
<th class="infobox-header" colspan="2">Universitat de Barcelona</th>
</tr>
<tr>
<td class="label">Location</td>
<td>Barcelona, Catalonia, Spain</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Public university</td>
</tr>
<tr>
<td class="label">Founded</td>
<td>1450</td>
</tr>
<tr>
<td class="label">Website</td>
<td><a href="https://www.ub.edu/" target="_blank">Universitat de Barcelona official site</a></td>
</tr>
<tr>
<td class="label">Neurodegeneration Focus</td>
<td>Alzheimer's Disease, Parkinson's Disease, Neuroscience, Aging</td>
</tr>
<tr>
<td class="label">Major Units</td>
<td>Faculty of Biology, Faculty of Medicine, Institute of Neuroscience</td>
</tr>
</table>

Universitat de Barcelona

Overview

...

<table class="infobox infobox-institution">
<tr>
<th class="infobox-header" colspan="2">Universitat de Barcelona</th>
</tr>
<tr>
<td class="label">Location</td>
<td>Barcelona, Catalonia, Spain</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Public university</td>
</tr>
<tr>
<td class="label">Founded</td>
<td>1450</td>
</tr>
<tr>
<td class="label">Website</td>
<td><a href="https://www.ub.edu/" target="_blank">Universitat de Barcelona official site</a></td>
</tr>
<tr>
<td class="label">Neurodegeneration Focus</td>
<td>Alzheimer's Disease, Parkinson's Disease, Neuroscience, Aging</td>
</tr>
<tr>
<td class="label">Major Units</td>
<td>Faculty of Biology, Faculty of Medicine, Institute of Neuroscience</td>
</tr>
</table>

Universitat de Barcelona

Overview

Universitat De Barcelona plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Introduction

The Universitat de Barcelona (UB) is Spain's oldest and largest university, founded in 1450. Located in Barcelona, Catalonia, the university is a major center for neuroscience and neurodegenerative disease research in Europe. With over 100,000 students, UB combines excellence in basic science with strong clinical research programs in neurological diseases [1].

History

The Universitat de Barcelona has been a center of scientific excellence since its founding in 1450. The university's medical and biology faculties have developed renowned research programs in neuroscience over the past several decades, establishing UB as a leading institution for neurodegenerative disease research in Spain and Europe.

Academic Structure

Faculty of Biology

The Faculty of Biology conducts fundamental research in:

• Molecular mechanisms of neurodegeneration
• Protein aggregation and clearance pathways
• Cell biology of neuronal health and disease
• Developmental neuroscience
• Neuroimmunology

Faculty of Medicine

The Faculty of Medicine supports:

• Clinical research in neurodegenerative diseases
• Epidemiology and population studies
• Translational research
• Clinical trials for novel therapeutics

Institute of Neuroscience (Institut de Neurociències)

The Institute of Neuroscience coordinates interdisciplinary research across departments, focusing on:

• Alzheimer's disease pathogenesis and therapy
• Parkinson's disease and movement disorders
• Amyotrophic lateral sclerosis (ALS)
• Multiple sclerosis
• Neurodegeneration in aging

Key Research Areas

Alzheimer's Disease Research

UB researchers investigate:

• [Amyloid precursor protein](/entities/app-protein) (APP) processing and [amyloid-beta](/proteins/amyloid-beta) generation
• [Tau](/proteins/tau) protein pathology and spreading mechanisms
• Neuroinflammation and microglial activation
• Synaptic dysfunction in early AD
• Biomarker discovery for early diagnosis
• Genetic risk factors in Spanish populations

Parkinson's Disease Research

Research programs focus on:

• [Alpha-synuclein](/proteins/alpha-synuclein) aggregation and propagation
• Mitochondrial dysfunction in dopaminergic [neurons](/entities/neurons)
• Leucine-rich repeat kinase 2 (LRRK2) biology
• [GBA](/entities/gba) gene mutations in PD risk
• Deep brain stimulation outcomes
• Non-motor symptoms of PD

Neurodegeneration and Aging

The university studies:

• Cellular mechanisms of brain aging
• Mitochondrial dysfunction in neurodegeneration
• Oxidative stress and DNA damage responses
• Protein quality control systems ([autophagy](/entities/autophagy), ubiquitin-proteasome)
• Neurotrophic factor signaling

Notable Research Groups

Neurobiology of Aging Group

Led by Dr. Isidre Ferrer, this group studies the neurobiology of aging and neurodegenerative diseases, with particular focus on protein aggregation disorders and neuropathology of aging brains [2].

Neurodegeneration Research Unit

This unit investigates molecular mechanisms of neurodegeneration, including:

• Prion protein dynamics
• RNA binding proteins in ALS/FTD
• Mitochondrial quality control
• Calcium dysregulation in neuronal death

Clinical Collaboration

UB maintains close collaboration with:

• Hospital Clínic de Barcelona - Major teaching hospital
• Hospital de la Santa Creu i Sant Pau
• IDIBAPS (Biomedical Research Institute August Pi i Sunyer)
• Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED)

International Collaboration

UB participates in major European research initiatives:

• Joint Programme on Neurodegenerative Disease Research (JPND)
• European Alzheimer's Disease Initiative
• Horizon Europe research programs
• International Consortium on Alzheimer's Genetics

Training Programs

The university offers:

• Master's in Neuroscience
• PhD programs in Biomedical Sciences
• Clinical residency training in Neurology
• Postdoctoral research positions
• International student exchange programs

Alzheimer's Disease Research Program

The Universitat de Barcelona hosts a comprehensive Alzheimer's disease research program, investigating multiple aspects of disease pathogenesis and therapy. The work of Ferrer (2018) on the neuropathology of Alzheimer's disease has been instrumental in understanding the disease's progression[@ferrer2018], and UB researchers extend this knowledge through local population studies.

Amyloid and Tau Pathology

UB researchers investigate the fundamental mechanisms of amyloid-beta and tau protein accumulation in the brain:

• APP processing: Characterizing the enzymatic cleavage of [amyloid precursor protein](/entities/app-protein) (APP) that generates amyloid-beta peptides
• Amyloid aggregation: Studying the formation of toxic oligomers and plaques
• Tau phosphorylation: Investigating the kinases and phosphatases that regulate tau modification
• Tau spreading: Understanding how pathological tau propagates between neurons

Pascoal et al. (2020) demonstrated that amyloid and tau biomarkers provide complementary information for Alzheimer's disease diagnosis and tracking[@pascoal2020], enabling UB researchers to develop novel biomarker combinations for early detection.

Neuroinflammation

The university's research program emphasizes the critical role of neuroinflammation in Alzheimer's disease:

• Microglial activation: Characterizing the phenotypic changes in microglia during disease progression
• Inflammatory cytokines: Investigating how IL-1β, TNF-α, and other cytokines contribute to neuronal dysfunction
• Complement system: Studying the role of complement proteins in synaptic elimination
• Therapeutic targets: Identifying anti-inflammatory approaches that may modify disease progression

Neff et al. (2023) comprehensively reviewed neuroinflammation as a key driver of Alzheimer's disease pathogenesis[@neff2023], providing a framework for UB researchers investigating this critical mechanism.

Synaptic Dysfunction

Understanding the early synaptic changes that precede neuronal loss is a priority for UB researchers:

• Synaptic proteomics: Identifying the protein networks disrupted in early disease
• Electrophysiology: Characterizing changes in synaptic plasticity and transmission
• Structural analysis: Using electron microscopy to examine synaptic morphology
• Restore strategies: Testing interventions that may protect synaptic function

Selkoe's seminal work established that synaptic failure correlates with cognitive decline in Alzheimer's disease[@selkoe2019], and UB researchers build upon this foundation to identify protective strategies.

Parkinson's Disease Research Program

UB maintains a robust Parkinson's disease research program that addresses both motor and non-motor symptoms of the disease.

Alpha-Synuclein Biology

Research focuses on understanding the aggregation and propagation of [alpha-synuclein](/proteins/alpha-synuclein):

• Oligomer formation: Characterizing the toxic species that initiate cellular dysfunction
• Cell-to-cell transmission: Studying how pathological proteins spread through the brain
• Strain diversity: Investigating whether different alpha-synuclein strains produce distinct clinical phenotypes
• Clearance mechanisms: Enhancing cellular pathways that remove pathological proteins

Paz et al. (2020) provided a comprehensive review of new insights into Parkinson's disease pathogenesis[@paz2020], guiding UB researchers in identifying novel therapeutic targets.

Motor and Non-Motor Symptoms

Beyond the classical motor features, UB researchers investigate the diverse non-motor manifestations:

• Sleep disorders: REM sleep behavior disorder as a prodromal marker
• Olfactory dysfunction: Loss of smell as an early diagnostic feature
• Autonomic dysfunction: Gastrointestinal and cardiovascular manifestations
• Cognitive impairment: Dementia associated with advanced Parkinson's disease

Kalia and Lang (2015) systematically reviewed Parkinson's disease, providing the foundational framework for UB clinical research programs[@kalia2015].

Genetic Factors

The university investigates both sporadic and genetic forms of Parkinson's disease:

• LRRK2 biology: Understanding the most common genetic cause of Parkinson's disease
• GBA mutations: Characterizing how glucocerebrosidase variants increase risk
• Polygenic risk: Identifying the combined effect of multiple genetic variants
• Gene-environment interactions: Studying how genetic susceptibility interacts with environmental exposures

Neurodegeneration Mechanisms

UB researchers study the common mechanisms that underlie various neurodegenerative diseases:

Protein Quality Control

The university investigates cellular systems responsible for maintaining protein homeostasis:

• Autophagy: Characterizing lysosomal and macroautophagy pathways
• Ubiquitin-proteasome: Understanding the role of the proteasome in clearing misfolded proteins
• Chaperone systems: Investigating molecular chaperones that assist protein folding
• Aggresome formation: Studying how cells sequester toxic protein aggregates

Chartier and Duyckaerts (2024) recently proposed that Alzheimer's disease may fundamentally be a lysosomal disorder[@chartier2024], opening new therapeutic directions that UB researchers are exploring.

Mitochondrial Dysfunction

The role of impaired energy metabolism in neurodegeneration is a major research focus:

• Oxidative phosphorylation: Characterizing defects in the electron transport chain
• Calcium homeostasis: Understanding how mitochondrial calcium handling goes awry
• Apoptosis pathways: Investigating the triggers of programmed cell death
• Metabolic therapies: Testing approaches that may improve cellular energy production

Neurotrophic Factor Signaling

The university studies how growth factors that support neuronal survival are affected in neurodegeneration:

• BDNF signaling: Understanding how brain-derived neurotrophic factor supports synaptic function
• GDNF family: Investigating glial cell line-derived neurotrophic factor approaches
• Receptor biology: Characterizing the cell surface receptors that mediate neurotrophic effects
• Therapeutic delivery: Testing novel methods for delivering growth factors to the brain

Clinical Research Infrastructure

UB's clinical research capabilities enable translation of basic science discoveries:

Hospital Clínic de Barcelona Collaboration

The partnership with Hospital Clínic provides:

• Clinical trial infrastructure: Access to Phase I-III trials for new therapeutics
• Patient cohorts: Well-characterized populations for biomarker studies
• Neuroimaging: State-of-the-art MRI and PET facilities
• Neuropsychology: Comprehensive cognitive assessment capabilities

IDIBAPS Partnership

The Biomedical Research Institute August Pi i Sunyer (IDIBAPS) provides:

• Basic science laboratories: State-of-the-art facilities for molecular and cellular research
• Translational programs: Bridging basic discoveries to clinical applications
• Training opportunities: Fellowship programs for physician-scientists
• International networks: Connections to major research consortia worldwide

CIBERNED Integration

The university participates in the Biomedical Research Network for Neurodegenerative Diseases (CIBERNED), enabling:

• Multi-center studies: Collaborative projects across Spanish institutions
• Sample sharing: Access to biobanks of brain tissue and cerebrospinal fluid
• Clinical expertise: Sharing of specialized clinical knowledge
• Resource pooling: Combined resources for large-scale projects

Training and Education

UB provides comprehensive training in neurodegenerative disease research:

Graduate Programs

• Master's in Neuroscience: One-year program providing foundational knowledge
• PhD in Biomedical Sciences: Three-to-four year research training
• Clinical research training: Programs for medical doctors pursuing research careers

Postdoctoral Opportunities

• Basic science positions: Laboratory positions in neuroscience research
• Clinical research fellowships: Training in clinical trial design and execution
• International exchanges: Programs for training at partner institutions

Continuing Education

• Physician education: Courses for practicing neurologists and geriatricians
• Caregiver training: Programs for family members and professional caregivers
• Public awareness: Educational programs for the general public

International Collaboration

UB maintains active collaborations with leading institutions worldwide:

European Networks

• Joint Programme on Neurodegenerative Disease Research (JPND): European initiative for coordinated research
• European Alzheimer's Disease Consortium (EADC): Multi-center collaboration on clinical research
• Horizon Europe: Participation in funded European research projects

Global Partnerships

• Alzheimer's Association: Collaboration on international research initiatives
• Michael J. Fox Foundation: Partnership on Parkinson's disease research
• International Parkinson and Movement Disorders Society: Participation in global networks

Research Visits

The university hosts international scientists through:

• Visiting professor programs: Extended stays for collaborative research
• Conference hosting: Annual symposiums bringing together international experts
• Student exchanges: Programs for graduate students to train abroad

See Also

• [Institutions](/institutions) - All institution pages
• [Alzheimer's Disease](/diseases/alzheimers-disease) - Alzheimer's disease mechanisms
• [Parkinson's Disease](/diseases/parkinsons-disease) - Parkinson's disease mechanisms

External Links

• [Universitat de Barcelona](https://www.ub.edu/) - Official website
• [Faculty of Biology](https://www.ub.edu/biologia/)
• [Faculty of Medicine](https://www.ub.edu/medicina/)
• [Institute of Neuroscience](https://www.ub.edu/neurociencies/)

References

{#references}